Cargando…

Clinical significance of aberrant mammalian target of rapamycin expression in stage IIIB colon cancer

The aim of the present study was to investigate the significance of aberrant expression of mammalian target of rapamycin (mTOR) and the activated form of mTOR kinase, phosphorylated mTOR (pmTOR), in human stage IIIB colon cancer. The expression of mTOR and pmTOR was detected by immunohistochemistry...

Descripción completa

Detalles Bibliográficos
Autores principales:	WEN, MEILING, LI, BAOXIU, CAO, XIAOFEI, WENG, CHENGYIN, WU, YONG, FANG, XISHENG, ZHANG, XIAOSHI, LIU, GUOLONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114703/ https://www.ncbi.nlm.nih.gov/pubmed/25120661 http://dx.doi.org/10.3892/ol.2014.2285

Ejemplares similares

IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma
por: Lu, Lin, et al.
Publicado: (2016)

Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma
por: Fang, Xisheng, et al.
Publicado: (2020)

MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway
por: Lu, Lin, et al.
Publicado: (2019)

Silencing UBE4B induces nasopharyngeal carcinoma apoptosis through the activation of caspase3 and p53
por: Weng, Chengyin, et al.
Publicado: (2019)

Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma
por: Liu, Xia, et al.
Publicado: (2022)

CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells
por: Lu, Lin, et al.
Publicado: (2020)

Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway
por: Lu, Lin, et al.
Publicado: (2022)

Neuron specific enolase promotes tumor metastasis by activating the Wnt/β-catenin pathway in small cell lung cancer
por: Zha, Zhiqiang, et al.
Publicado: (2021)

Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions
por: Xu, Gongjun, et al.
Publicado: (2021)

Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells
por: Liu, Xia, et al.
Publicado: (2019)

No relationship between the distribution of mast cells and the survival of stage IIIB colon cancer patients
por: Xia, Qing, et al.
Publicado: (2011)

CPNE8 Promotes Gastric Cancer Metastasis by Modulating Focal Adhesion Pathway and Tumor Microenvironment
por: Zhang, Peiling, et al.
Publicado: (2022)

Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma
por: Li, Shau-Hsuan, et al.
Publicado: (2017)

Higher percentage of CD133(+ )cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
por: Li, Chun-Yan, et al.
Publicado: (2009)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Ventilation in patients with stage IIIB or above lung cancer
por: Zhang, Haiqin, et al.
Publicado: (2021)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial
por: Hadji, Peyman, et al.
Publicado: (2018)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

Surgery for stage IIB–IIIB small cell lung cancer
por: Huang, Zhida, et al.
Publicado: (2023)

Survival Contradiction in Stage II, IIIA, And IIIB Colon Cancer: A Surveillance, Epidemiology, and End Result-Based Analysis
por: Li, Yijun, et al.
Publicado: (2022)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Driving neural regeneration through the mammalian target of rapamycin
por: Maiese, Kenneth
Publicado: (2014)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

Autism Spectrum Disorder and Mammalian Target of Rapamycin System
por: Posar, Annio, et al.
Publicado: (2020)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

Prognostic Significance of Periostin and Mammalian Target of Rapamycin (mTOR) in Locally Advanced Esophageal Squamous Cell Carcinoma
por: Jiang, Qi, et al.
Publicado: (2017)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Mammalian Tribbles Homologs at the Crossroads of Endoplasmic Reticulum Stress and Mammalian Target of Rapamycin Pathways
por: Cunard, Robyn
Publicado: (2013)

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
por: Weng, Chengyin, et al.
Publicado: (2021)

Ionic liquids IIIB
por: Rogers, Robin D, et al.
Publicado: (2005)

Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis
por: Sun, Yuting, et al.
Publicado: (2010)

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
por: Xu, Da-zhi, et al.
Publicado: (2010)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders
por: Chong, Zhao Zhong, et al.
Publicado: (2010)

New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
por: Agulnik, Mark
Publicado: (2012)

Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2013)

The cytotoxic T cell proteome and its shaping by mammalian Target of Rapamycin
por: Hukelmann, Jens L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2uhmst9u0gkad3n7m389nk50fk